查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1454249

全球更年期治療市場：依治療類型、給藥途徑、劑型、適應症、通路及地區

Global Menopause Treatment Market, By Treatment Type, By Route of Administration, By Form, By Indication, By Distribution Channel, By Geography .
出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年全球更年期治療市場價值為153.3億美元，預計2024年至2031年年複合成長率為5.9%，到2031年達到243.3億美元。

報告範圍 報告詳情
基準年 2023年 2023/2024年市場規模 153.3億美元
實際資料 2019-2023 預測期 2024-2031
預測期2023/2024~2030/2031年複合成長率： 5.90% 2030/2031價值預測 243.3億美元
圖 1. 2023 年按地區分類的更年期治療的全球市場佔有率(%)
全球更年期治療市場-IMG1

更年期是一種自然的生物過程，通常發生在女性 45 歲至 55 歲之間。更年期標誌著女性生育期的結束和生育後生活的過渡。更年期最常見的徵兆和症狀包括月經、潮熱、盜汗、陰道乾燥、情緒變化和睡眠問題。隨著更年期的進展，女性的雌激素水平急劇下降，如果不加以控制，可能會導致長期的健康風險。因此，管理這種過渡狀況是許多女性的首要任務。全球更年期治療市場為患有更年期症狀的女性提供了多種治療選擇。

市場動態：

由於生活方式的改變和健康意識的提高，女性更年期盛行率的增加是推動全球更年期治療市場成長的關鍵因素。根據大量研究，大約四分之一的 40 歲至 60 歲女性表示至少經歷過一種與更年期相關的問題症狀。久坐工作和缺乏運動也會增加過早閉經和過早閉經的風險。此外，大型製藥企業核准和推出新產品正在擴大解決更年期血管舒縮症狀的治療選擇。然而，與荷爾蒙補充療法相關的副作用和替代治療方案的可用性仍然在一定程度上限制了市場潛力。此外，新興國家對治療的認知度較低也是市場相關人員面臨的挑戰。儘管如此，亞太地區更年期護理的技術進步和醫療旅遊的擴張預計將在未來幾年為相關人員提供利潤豐厚的機會。

本研究的主要特點

  • 本報告對全球更年期治療市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。
  • 它還說明了各個細分市場的潛在收益成長機會，並為該市場提供了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球更年期治療市場的主要企業。
  • 該報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球更年期治療市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球更年期治療市場的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章 市場動態、法規與趨勢分析

  • 市場動態
    • 新產品發布
    • 老年人口增加
    • 透過資金和投資提供財政支持
  • 影響分析
  • 主要亮點
  • 市場趨勢
  • PEST分析
  • 監管場景
  • 合併、收購和合作
  • 主要提供服務
  • 治療費用分析
  • 識別頂級市場參與者
  • 政府措施和投資
  • 品牌映射和價格分析
  • 按國家/地區分類的醫療保健支出

第4章全球更年期治療市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章全球更年期治療市場，依治療類型，2019-2031

  • 荷爾蒙療法
  • 雌激素類藥物
  • 黃體素藥物
  • 組合藥物（雌激素與黃體素、雌激素與其他藥物）
  • 非荷爾蒙療法
  • 神經激肽 3 (NK3)
  • 受體拮抗
  • 選擇性血清素
  • 再回收抑制劑（SSRIs）
  • 其他

第6章全球更年期治療市場，依給藥途徑，2019-2031

  • 口服
  • 外用
  • 胃腸外的
  • 陰道
  • 其他

第7章全球更年期治療市場，按劑型，2019-2031

  • 錠劑
  • 奶油
  • 修補
  • 子宮托
  • 注射
  • 其他

第8章全球更年期治療市場（按適應症），2019-2031

  • 閉經
  • 停經
  • 停經後

第9章全球更年期治療市場，依通路，2019-2031

  • 醫院藥房
  • 零售藥房
  • 網路藥房
  • 專賣店
  • 其他

第10章全球更年期治療市場，按地區，2019-2031

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第11章競爭格局

  • 公司簡介
    • Novartis AG
    • Pfizer Inc.
    • Bayer AG
    • Teva Pharmaceutical Industries Ltd.
    • AbbVie Inc.
    • Novo Nordisk A/S
    • illendo Therapeutics, Inc.
    • Mithra Pharmaceuticals
    • Merck &Co., Inc
    • Cipla Inc.
    • Abbott
    • Viatris Inc.
    • Organon
    • SnapNurse
    • Glenmark Pharmaceuticals Limited
    • Procter &Gamble
    • Duchesnay USA.
    • TherapeuticsMD, Inc.
    • Avion Pharmaceuticals
    • KWS
    • PharmaCare Europe Ltd.
    • Amneal Pharmaceuticals LLC.

第12章 章節

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6676

The global menopause treatment market was valued US$ 15.33 Bn in 2023 and is expected to reach US$ 24.33 Bn by 2031 growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 15.33 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 5.90% 2030/2031 Value Projection: US$ 24.33 Bn
Figure 1. Global Menopause Treatment Market Share (%), By Region, 2023
Global Menopause Treatment Market - IMG1

Menopause is a natural biological process that usually occurs between the ages of 45 to 55 years in women. It marks the end of a woman's reproductive years and the transition into her post-reproductive life. Some of the most common signs and symptoms of menopause include irregular menstrual periods, hot flashes, night sweats, vaginal dryness, mood changes, and difficulty sleeping. As menopause progresses, a woman's estrogen levels drop dramatically, which could lead to several long-term health risks if left untreated. Therefore, managing symptoms during this transitional phase has become a priority for many women. The global menopause treatment market offers a variety of treatment options for women suffering from menopause symptoms.

Market Dynamics:

The rising prevalence of menopause issues among women owing to changing lifestyle patterns and growing health awareness levels is a key factor driving the growth of global menopause treatment market. Numerous researches have shown that approximately one-fourth of women within the age group of 40 to 60 years report experiencing at least one problematic symptom associated with menopause. There is also the emergence of sedentary jobs and a lack of physical activity, which has escalated the risks of premature or early menopause. Additionally, new product approvals and launches by leading pharmaceutical players are expanding the treatment choices for addressing vasomotor symptoms during menopause. However, side effects associated with hormone replacement therapy and the availability of alternative treatment options still limit the market potential to a certain extent. Moreover, a lack of awareness about treatment in developing nations poses a challenge to market players. Nonetheless, technological advancements in menopausal care and growing medical tourism in the Asia Pacific region are expected to unlock lucrative opportunities for stakeholders in coming years.

Key Features of the Study:

  • This report provides an in-depth analysis of the global menopause treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global menopause treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Novartis AG, Pfizer Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Novo Nordisk A/S, illendo Therapeutics, Inc., Mithra Pharmaceuticals, Merck & Co., Inc, Cipla Inc., Abbott, Viatris Inc., Organon, SnapNurse, Glenmark Pharmaceuticals Limited, Procter & Gamble, Duchesnay USA., TherapeuticsMD, Inc., Avion Pharmaceuticals, KWS, PharmaCare Europe Ltd., Amneal Pharmaceuticals LLC.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global menopause treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global menopause treatment market

Detailed Segmentation:

  • Global Menopause Treatment Market, By Treatment Type
    • Hormone Therapy
    • Estrogen-based Drugs
    • Progestin-based Drugs
    • Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
    • Non-hormonal Therapy
    • Neurokinin 3 (NK3)
    • Receptor Antagonist
    • Selective Serotonin
    • Reuptake Inhibitor (SSRI)
    • Others
    • Others
  • Global Menopause Treatment Market, By Route of Administration
    • Oral
    • Topical
    • Parenteral
    • Vaginal
    • Others
  • Global Menopause Treatment Market, By Form
    • Tablets
    • Creams
    • Patches
    • Pessaries
    • Injections
    • Others
  • Global Menopause Treatment Market, By Indication
    • Perimenopause
    • Menopause
    • Postmenopause
  • Global Menopause Treatment Market, By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Specialty Stores
    • Others
  • Global Menopause Treatment Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Top Companies in the Global Menopause Treatment Market:
    • Novartis AG
    • Pfizer Inc.
    • Bayer AG
    • Teva Pharmaceutical Industries Ltd.
    • AbbVie Inc.
    • Novo Nordisk A/S
    • illendo Therapeutics, Inc.
    • Mithra Pharmaceuticals
    • Merck & Co., Inc
    • Cipla Inc.
    • Abbott
    • Viatris Inc.
    • Organon
    • Glenmark Pharmaceuticals Limited
    • Procter & Gamble
    • Duchesnay USA.
    • TherapeuticsMD, Inc.
    • Avion Pharmaceuticals
    • KWS
    • PharmaCare Europe Ltd.
    • Amneal Pharmaceuticals LLC.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Treatment Type
    • Market Snippet, By Route of Administration
    • Market Snippet, By Form
    • Market Snippet, By Indication
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • New Product Launches
    • Rising Geriatric Population
    • Financial Support Through Funding And Investments
  • Impact Analysis
  • Key Highlights
  • Market Trends
  • PEST Analysis
  • Regulatory Scenario
  • Mergers, Acquisitions, and Collaborations
  • Key Services Offered
  • Treatment cost Analysis
  • Identification of Top Market Players
  • Government Initiatives and Investments
  • Brand Mapping & Pricing Analysis
  • Healthcare Spending by Country

4. Global Menopause Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Menopause Treatment Market, By Treatment Type, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hormone Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Estrogen-based Drugs
  • Progestin-based Drugs
  • Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
  • Non-hormonal Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Neurokinin 3 (NK3)
  • Receptor Antagonist
  • Selective Serotonin
  • Reuptake Inhibitor (SSRI)
  • Others
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Menopause Treatment Market, By Route of Administration, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Vaginal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Menopause Treatment Market, By Form, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Creams
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Pessaries
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Injections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Menopause Treatment Market, By Indication, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Perimenopause
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Menopause
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Postmenopause
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

9. Global Menopause Treatment Market, By Distribution Channel, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Specialty Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

10. Global Menopause Treatment Market, By Region, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region/Country, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region/Country, 2020 - 2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

  • Company Profile
    • Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Pfizer Inc.
    • Bayer AG
    • Teva Pharmaceutical Industries Ltd.
    • AbbVie Inc.
    • Novo Nordisk A/S
    • illendo Therapeutics, Inc.
    • Mithra Pharmaceuticals
    • Merck & Co., Inc
    • Cipla Inc.
    • Abbott
    • Viatris Inc.
    • Organon
    • SnapNurse
    • Glenmark Pharmaceuticals Limited
    • Procter & Gamble
    • Duchesnay USA.
    • TherapeuticsMD, Inc.
    • Avion Pharmaceuticals
    • KWS
    • PharmaCare Europe Ltd.
    • Amneal Pharmaceuticals LLC.
  • Analyst Views

12. Section

  • References
  • Research Methodology
  • About us